therapeutics glp 1 activate GLP-ONE Activator Bundle History of glucagon-like peptide-1 receptor

Clinicians and researchers should address the high rates of skeletal muscle loss following GLP-1RA treatment and attempt to mitigate such losses to prevent complications associated with sarcopenia [163,164]

So when Stephen Bloom's paper came out in January of 1996, and he was the first one to call GLP-1 a neurotransmitter, I think, but I was already way into actually screening these kind of molecules that later then became liraglutide

Use the appetite suppression as a tool, not as your entire strategy

However, without robust appetite modulation, the long-term effect on body composition may be limited

And then we started tailoring doses per person, depending on their response and their unique physiology